AI assistant
Sending…
Arcadia Biosciences, Inc. — Director's Dealing 2019
Nov 19, 2019
35424_dirs_2019-11-19_5344b577-04e3-4423-83cd-915bc2ae8466.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2019-11-18
Reporting Person: Murray Lilian Shackelford (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-11-18 | Common stock | P | 5000 | $4.25 | Acquired | 8524 | Direct |
More from Arcadia Biosciences, Inc.
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Feb 6
Regulatory Filings
2026
Jan 28
Regulatory Filings
2026
Jan 14
Regulatory Filings
2025
Dec 29
Regulatory Filings
2025
Dec 29
Regulatory Filings
2025
Dec 23
Annual Report
2025
Nov 19